Portman Square Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-164,300
Closed -$51.6M 161
2025
Q2
$51.6M Buy
164,300
+20,600
+14% +$5.95M 1.51% 18
2025
Q1
$37.7M Buy
143,700
+12,300
+9% +$3.33M 1% 25
2024
Q4
$34.3M Sell
131,400
-40,000
-23% -$10.1M 1.23% 16
2024
Q3
$39.9M Hold
171,400
1.49% 9
2024
Q2
$34.6M Buy
171,400
+36,400
+27% +$6.56M 1.19% 13
2024
Q1
$23.1M Buy
135,000
+5,000
+4% +$932K 0.64% 46
2023
Q4
$28.2M Hold
130,000
0.65% 38
2023
Q3
$20.7M Buy
130,000
+88,400
+213% +$19.8M 0.51% 52
2023
Q2
$12M Sell
41,600
-18,000
-30% -$5.47M 0.34% 79
2023
Q1
$19M Buy
59,600
+7,400
+14% +$2.19M 0.87% 28
2022
Q4
$15.4M Buy
+52,200
New +$14.4M 1.13% 21

Other funds holding PODD

Portman Square Capital's PODD Position: Q3 2025 in Review

Portman Square Capital sold out of Insulet (PODD) in Q3 2025, closing a stake of 41,723 shares — an estimated $13.1M sold.

Portman Square Capital first reported a position in PODD in Q4 2022 and held it in 10 quarters. The position peaked at $26.4M in Q1 2023. 813 funds tracked by Wall St. Rank hold PODD as of Q3 2025.

  • Portman Square Capital reported no remaining Insulet position as of Q3 2025 after selling out during the quarter.
  • Portman Square Capital sold 41,723 Insulet shares in Q3 2025, an estimated $13.1M.
  • Portman Square Capital first reported a position in Insulet in Q4 2022 and held it in 10 quarters.
  • Portman Square Capital's Insulet position peaked at $26.4M in Q1 2023.
  • 813 funds tracked by Wall St. Rank held Insulet as of Q3 2025.

Based on Portman Square Capital's 13F filing for Q3 2025, filed 16 Oct 2025.